The Rise Of GLP-1 Drugs In just three years, drugs like Ozempic have reshaped how society views the body. They reignited a ...

Have you evaluated the performance of Eli Lilly's (LLY) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of this drugmaker, ...

Patients presenting to the emergency department with esophageal food impaction commonly do not receive an esophageal biopsy to diagnose EoE, representing a missed diagnostic opportunity.

The menopausal transition is a pivotal time in women’s health, bringing about profound hormonal, metabolic and physiologic ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Eli Lilly and Company has outlined plans to develop a $3bn manufacturing facility in Katwijk, Leiden Bio Science Park, the ...

For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and ...

Increased our 2025 full-year revenue guidance to be in the range of $63.0 billion to $63.5 billion; reported EPS guidance raised to be in the range of $21.80 to $22.50 and non-GAAP EPS guidance raised ...

Lilly, an Indianapolis-based drugmaker, plans to build a $3 billion manufacturing plant in the Netherlands to boost ...

The partnership between LillyDirect and Walmart allows patients to pick up Zepbound at Walmart pharmacies at the same self-pay price as online. Sel ...